Ona Therapeutics

First-in-class ADCs tailored to attack advanced cancer.

Barcelona, United States · Founded 2019 · $152.1M raised

Headquarters
Barcelona
Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$152.1M
Last Round
$86.6M Series BJun 2026
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Ona Therapeutics is a biotechnology company, founded in 2019 and spun out of ICREA and IRB, pioneering first-in-class antibody drug conjugates (ADCs) that exploit the molecular underpinnings of advanced cancer. The company partners with renowned academics and clinicians to discover novel therapeutic targets from the unique biology of treatment-refractory advanced cancer patients, combining privileged biology with its expertise in biologics to craft ADCs and antibody therapies for patients with no remaining alternatives.

Summary

Ona Therapeutics is a Biotech company based in Barcelona, United States, founded in 2019. It has raised $152.1M in total across 4 rounds, most recently a $86.6M Series B round in Jun 2026. Investors include Asabys Partners, Ysios Capital and Alta Life Sciences.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJun 2026
$86.6M

Sign up to see all 4 events

Funding: Seed through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ona Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/ona-therapeutics"><img src="https://indexed.vc/api/badge/company/ona-therapeutics" alt="Ona Therapeutics on Indexed.vc" width="260" height="76" /></a>